Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds inhibiting leucine-rich repeat kinase enzyme activity

Compounds inhibiting leucine-rich repeat kinase enzyme activity

US Patent 9416126 · Granted Aug 16, 2016

Estimated economic value: $77,022,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AAV capsids for targeting nervous system and uses thereof2025
Hepatitis B antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Manufacture of compounds and compositions for inhibiting the activity of SHP22025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
Compounds for degrading alpha-synuclein aggregates and uses thereof2025
Metabolically stable pyrimidinyl dihydroquinoxalinones as tubulin polymerization2025
Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystr2025
Biodegradable ultra-pH sensitive polymers2025
Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhib2025